|
Erythromycin Ethylsuccinate And Sulfisoxazole AcetylDrug - Erythromycin Ethylsuccinate And Sulfisoxazole Acetyl The trade name of the product as shown on the labeling.
Dosage -
GRANULE; ORAL
Active Ingredient(s) -
Erythromycin Ethylsuccinate; Sulfisoxazole Acetyl
Strength -
EQ 200MG BASE/5ML;EQ 600MG BASE/5ML
Applicant -
BARR
New Drug Application (NDA) Number -
062759
Product Number -
001
Therapeutic Equivalence (TE) Code -
AB
Approval Date -
May 20, 1988
Reference Listed Drug (RLD) -
No
Type -
RX
Applicant Full Name -
Barr Laboratories Inc
Erythromycin Ethylsuccinate And Sulfisoxazole Acetyl
Eryped Eq 200mg Base Tablet, Chewable; Oral
Pediamycin Eq 200mg Base Tablet, Chewable; Oral E.E.S. 400 Eq 400mg Base Tablet; Oral E.E.S. 400 Eq 400mg Base Tablet; Oral Erythromycin Ethylsuccinate Eq 400mg Base Tablet; Oral Erythromycin Ethylsuccinate Eq 400mg Base Tablet; Oral Erythromycin Ethylsuccinate And Sulfisoxazole Acetyl Eq 200mg Base/5ml;eq 600mg Base/5ml Granule; Oral Wyamycin E Eq 200mg Base/5ml Suspension; Oral Wyamycin E Eq 400mg Base/5ml Suspension; Oral E.E.S. Eq 200mg Base Tablet, Chewable; Oral NewDrugInformation |